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Women’s lived experiences of learning to
live with osteoporosis: a longitudinal
qualitative study
Carrinna A. Hansen1,2*, Bo Abrahamsen3, Hanne Konradsen4 and Birthe D. Pedersen1
Abstract
Background: A vast amount of literature exists concerning pharmaceutical adherence in osteoporosis. However,
the process of learning to live with osteoporosis over time remains largely unknown. The purpose of this study was
to gain a deeper understanding of the continued process of how women learn to live with osteoporosis. Our objective
was to explore what characterizes women’s experiences of living with osteoporosis during the first year after diagnosis,
when patients are prescribed anti-osteoporotic treatment, without having experienced an osteoporotic fracture.
Methods: Forty-two narrative qualitative interviews were conducted with fifteen recently diagnosed Danish women. A
longitudinal design was chosen since this allows an investigation of the perspective over time. The interviews were
conducted in the period of March 2011 to August 2012. Data were analyzed using a phenomenological-hermeneutic
interpretation of text. No medical records were available for the researchers. All information with the exception of
T-score was self-reported.
Results: The participants’ experiences could be described in two key themes developed through the analysis: 1)
“To become influenced by the medical treatment” which consisted of two sub-themes “taking the medication”,
and “discontinuing the medication”. 2) “Daily life with osteoporosis”, which was characterized by three sub-themes:
“interpretation of symptoms”, “interpretation of the scan results” and “lifestyle reflections”. The results highlighted that
learning to live with osteoporosis is a multifaceted process that is highly influenced by the medical treatment. In some
cases, this is a prolonged process that can take around one year.
Conclusions: The results suggest a need for improved support for individual women during the complex process of
learning to live with osteoporosis. The study adds new knowledge that can be useful for healthcare professionals
taking a health-oriented stance when supporting women in self-management of their illness. Further investigations of
lived experiences over time in the field of osteoporosis research are therefore needed.
Keywords: Chronic disease, Denmark, Lived experiences, Longitudinal, Medical treatment, Newly-diagnosed,
Osteoporosis, Phenomenological-hermeneutic, Qualitative research, Women
Background
Osteoporosis is an increasing major public health problem
[1–3] which affects hundreds of millions of people world-
wide [4]. This condition is, however, greatly underdiag-
nosed and undertreated [3–5], leading to an increased
need for early detection, treatment and osteoporosis
education to prevent deterioration and disability [4, 5], as
well as the need to improve the prognosis [6], the quality
of life [7–9] and to prevent premature death [3, 10, 11].
Osteoporosis is a chronic condition that is generally treat-
able in otherwise healthy individuals but it can also
become severely debilitating if left untreated [2, 12].
Osteoporosis definition and causal explanations
The current definition of osteoporosis for post-menopausal
women was first proposed in 1944 by a Task Force under
the World Health Organization (WHO) [13]:
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“Severe osteoporosis (established osteoporosis). A bone
mineral density (BMD) that is more than 2.5 standard
deviation (SD) below the young adult mean in the
presence of one or more fragility fractures” pp. 6 [14].
The diagnosis is made on the basis of a Dual-energy
X-ray absorptiometry (DXA) scan and a quantitative as-
sessment of the BMD, which is a determinant of bone
strength. BMD is measured as a T-score in lumbar spine
or hip. Low BMD can be a risk factor but does not
always lead to fractures. The risk of fracture is highly
influenced by other factors such as age, heredity, Body
Mass Index, weight-bearing exercise and lifestyle [3, 15].
The most common physical consequences of osteopor-
osis are compression fractures of the spine, fracture at
the hip, distal forearm and proximal humerus.
Epidemiology and fracture
The prevalence of female osteoporosis in the five largest
countries in Europe (France, Germany, Italy, Spain and
the UK) is high, with 21% of women aged 50–84 years
(representing more than 12 million) being affected in
these countries [3]. In Denmark, there are no accurate
figures of how many individuals are affected by osteo-
porosis, partly because the disease is often asymptomatic
in the early stages and also because guidelines do not
consider systematic screening initiatives to be justified
[2, 16, 17]. However, Vestergaard et al. estimated in 1995
that 40.8% of women and 17.7% of men over 50 years of
age have osteoporosis in Denmark [5]. As a result of the
increase in the size of the aging population [15, 18]
along with an increased awareness of the condition, the
number of men and women diagnosed as living with
osteoporosis has also increased in recent decades.
Osteoporosis, consequences and challenges - a continued
public health problem
The consequences of osteoporosis include physical,
psychological, economic and societal factors [2, 10, 19].
It is a continued challenge to promote bone health and
to prevent osteoporotic fractures [6, 7, 20] in a growing
worldwide elderly population. This challenge is exac-
erbated by the fact that many individuals do not follow
the prescribed anti-osteoporotic treatment as recom-
mended [21–26]. Despite extensive investigations of this
phenomenon, it seems that the underlying causal explana-
tions of medication failure (such as quitting treatment
early or low compliance to treatment leading to lack of
treatment efficacy) [23] have not yet been fully explored. It
has been suggested that the research in the field of frac-
ture prevention treatment needs to focus on patients’ own
perceptions [23, 27, 28]. This type of research calls for the
use of qualitative research methods to make the voices of
those involved heard.
A thorough understanding of women’s experience of
osteoporosis
Studies have found that being diagnosed with osteoporosis
may lead to psychological and physical consequences for
the individuals, impacting their quality of life [8, 29–35].
In addition to this, patients may find it difficult to make
sense of the diagnosis and its implications for their current
and future health [8]. These difficulties may be associated
with the emotional challenges of handling the knowledge
of the fracture risk [29], as well as thoughts about osteo-
porosis and risk perception influenced by stereotypes of
bodily deterioration and founded on worst-case scenarios
[30] and interpretations of information derived from the
DXA scan as body fragility and risk [31]. There are a var-
iety of ways in which women with osteoporosis perceive
themselves and manage their chronic illness and ageing,
arguing that structural and psychological determinants of
health behavior need to be understood in order to better
understand and manage the disease [36, 37].
In the current study, we chose a qualitative method in
order to supplement former studies of osteoporosis. This
was chosen in order to explore the patient’s perspective
of osteoporosis, and to detect areas where improvements
in treatment could be made. The objective was to ex-
plore what characterizes women’s experiences of living
with osteoporosis in the first year after diagnosis, when
patients are prescribed anti-osteoporotic treatment,
without experiencing an osteoporotic fracture.
Methods
This qualitative study used a phenomenological-
hermeneutic approach of narratives and interpretation
[38–40]. The French philosopher Paul Ricoeur’s work is
commonly regarded as a bridge between the philosophies
of phenomenology and hermeneutic [41]. In this interpret-
ation, the structures of subjective experience and con-
sciousness, and the self and its realization are interpreted
through the hermeneutic circle [42]. The approach was
chosen in order to be open towards patients’ perspectives
when exploring women’s experiences, beliefs, attitudes,
behavior and lifestyle when living with a new diagnosis of
osteoporosis. Additionally, a longitudinal design was
chosen because it allows the tracking of changes over
time, and for examining development of patterns and
changes. This may provide a more comprehensive level of
information regarding individual experiences and percep-
tions [43].
The initial sampling of women 65 years or older who
attended DXA scan took place at two hospitals in two
different regions of Denmark. The methods of recruit-
ment and discussion of non-participators have been
reported elsewhere [44, 45]. In the present study, we in-
vestigated the experiences during the conversion to new
life circumstances with osteoporosis.
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Participants
Women were contacted when they attended a DXA scan
at one of the two participating hospitals during the
period of January to April 2011. Fifteen participants were
included consecutively according to inclusion and exclu-
sion criteria, the inclusion criteria being aged 65 years or
older, with a new diagnosis of osteoporosis and a DXA
scan showing a T-score below −2.5 (lower back or hip)
[13], as well as no previous known osteoporotic fracture
and self-reported confirmation of at least one of the
known risk factors [2]. In addition, all participants had
been prescribed anti-osteoporotic pharmaceutical treat-
ment. Exclusion criteria included signs of cognitive
impairment, a previous diagnosis of osteoporosis, or pre-
vious treatment with anti-osteoporotic medication. The
women who met the inclusion criteria were contacted
by a healthcare professional, given an information letter
and invited to participate in the study. Those who
agreed to participate gave their name and phone number
and were contacted shortly after by the researcher
(CAH). One woman did not wish to continue participat-
ing when contacted prior to the second interview-round
for personal reasons, and another was not reachable at
the time of the last interview.
Data source
The participants gave three interviews, for a total of 42
interviews for analysis. The first interview took place
shortly after diagnosis, the second interview about six
months later and the third interview approximately one
year after diagnosis. These points of time were chosen
because studies have shown that patients’ medical adher-
ence stabilizes around six months after initiation [46, 47]
and adjustments to live with a chronic condition may be
lengthy [48]. An open approach was used to encourage
the women to tell their individual stories of living with
osteoporosis. An open interview guide (Additional file 1)
was used [49]. Preliminary, to etch interview the women
were informed of the purpose of the study and informed
consent was obtained. Initially, the women were asked
an open-ended question: “Please tell me about your
experiences of living with osteoporosis?” The researcher
would then ask clarifying questions such as “Could you
please elaborate what you were telling me about xx?” to
capture the individual perspective [49]. The interview
guide was adjusted between interview-rounds [43]. Inter-
views were performed between March 2011 and August
2012 until data saturation was reached; they were
tape-recorded and subsequently transcribed verbatim.
Field notes were taken immediately after each inter-
view. No medical records were available for the re-
searchers and none of the women were patients of the
authors. All information with the exception of T-
scores were self-reported.
Ethical considerations
The study was approved by the Danish Data Protection
Agency (J.no. 2012-41-0875) and the National Commit-
tee on Health Research Ethics (J.no. H-C-FSP-2011_01),
following the Helsinki Declaration [50]. Informed writ-
ten consent was obtained at the time of enrolment and
oral consent before each interview.
Individual interviews were chosen in order to explore
the individual perspective in depth. The role of the first
author (CAH, while she remained Ph.D. student) as an
interviewer may have affected the interviews because the
participants knew that she was a nurse. The participants
expressed expectations of getting the opportunity to get
advice during the interview, however their questions
were kindly circumvented until after the interview was
completed. In accordance with ethical responsibilities’
and research principles, in most cases the women were
encouraged to contact their GPs or other relevant
healthcare professional for clarification of the questions,
as well as in cases of any other health related problem
which were considered needed to be examined by a
physician. On the other hand, it is also possible that the
participants were more open during the interviews due
to the interviewer’s healthcare profession, or due to the
interview performed in a private atmosphere in their
home [51]. However, the role as a nursing-researcher
may have been diminished by conducting the interviews
in the women’s homes, where the interaction was less af-
fected by the interviewer’s professional status as she was
a guest in the women’s homes.
Newly diagnosed patients’ are in a vulnerable situation
and the experience of participation in a research study
may possibly add an additional burden. When individ-
uals have an opportunity to talk about their own experi-
ences, they may gain meaning and understanding
through telling their story which may be helpful when
adapting to difficult situations [48]. This may have been
the case for several of the participating women, as they
spontaneously described that they had chosen to partici-
pate in the project in order to have the opportunity to
gain a better understanding of osteoporosis.
Throughout the data collection the participants’ needs
were looked after through attentiveness to the individual
needs and wishes in relation to interview time and
location.
Analysis
According to the chosen approach, the analysis of the
transcribed interviews consisted of three levels: naïve
reading, a structured analysis and a critical interpret-
ation and discussion. The analysing process took place
through a dialectical movement between the parts and
the whole, performed in a helical process [38–40]. In
this manner, as illustrated in Fig. 1. an interpretation
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was performed and a new understanding of living with
osteoporosis arose through the key themes and sub
themes elaborated in the level of structural analysis.
The text is read several times in order to comprehend
its meaning as a whole. The interpreter tries to read the
text with an open mind, to allow the text to “speak”.
The naïve reading is the first assumptions regarding the
content of the text [39, 40]. The movement from what
the text says to what it discusses was followed according
to the descriptions of understanding a text in the struc-
tural analysis [39, 40] - this interpretation level is exem-
plified in Table 1.
The final interpretation is preceded by a critical
analysis, continuing the dialectic process between
explanation and comprehension as a discussion of
relevant literature and other research findings relating
to the interpretation level.
Results
The study comprised 42 interviews with 15 women with
osteoporosis ranging from 65 to 79 years (at the time of
the first interview). The interviews lasted between 12
and 78 min (mean 57.48). The description of the inter-
view process is illustrated in Fig. 2.
Most interviews were conducted at participants’
private homes, but three participants chose to give
their interviews at the hospital and, at the third
interview-round, five interviews were conducted by
telephone. Most women had a history of hereditary
osteoporosis; more than half of the women had daily
back pain and all except three reported other comor-
bidities (primarily cancer, chronic pulmonary lung dis-
ease and collagen disease), together with some other
self-reported socio-demographic information, pre-
sented in Table 2.
The naïve reading gave an insight about the text. Expe-
riences of learning to live with osteoporosis were
described in terms of a cognitive process of meaning
creation, understanding and coming to terms with the
new life circumstances and medical treatment. Descrip-
tions were related to the development of an understand-
ing through interpretation and reflection relating to side
effects and other physical symptoms, and the interpret-
ation and value of DXA scan results and lifestyle. This
Fig. 1 Analytic levels in the interpretation of text
Table 1 An example of the structural analysis and themes
Meaningful units
what is said
‘Quotes’
↔ Significant units
what is spoken about
(primary interpretation)
↔ Sub themes ↔ Themes
emissions of key themes
(1st interview round) ‘I am confused; I do not know what might
harm. (…) I want to do preventive things as much as possible.
(…)Does it takes ten years to develop a fracture or how fast?
How unfortunate can I be? Will something suddenly break?
Many people are having pain, that is turning around in my
head after I have been told that I have osteoporosis’
being insecure when wanting to
prevent uncertain consequences
Lifestyle reflection Daily life with osteoporosis
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led to two key themes that emerged through the struc-
tural analysis: 1) “to become influenced by the medical
treatment” and 2) “daily life with osteoporosis”. The
two themes were found to describe overarching choices
and strategies of living with osteoporosis. These were
found to develop over time. From the descriptions
shortly after diagnosis, through a further elaboration
six month later and finally a pattern of living with
osteoporosis approximately one year after diagnosis. An
overview of the key themes and sub themes are pre-
sented in Table 3.
The themes will subsequently be described within the
interpretation.
To become influenced by the medical treatment
Experiences of becoming influenced by the medical
treatment were described in the first round of inter-
views, the main focus being on practical issues of how to
take the prescribed medication and how to manage side
effects. This focus on side effects continued through the
second and third round of interviews and a need to seek
information and advice was also described. This ap-
peared to be a cognitive process, as reflected in decisions
regarding whether to take or reject the medication. The
key theme was described as a trajectory illuminated by
two subthemes: “taking the medication” and “discontinu-
ing the medication”.
Taking the medication
At the first interview shortly after the diagnosis, taking
the medication was described as a challenge: this was
particularly true the first time the medication had to be
Fig. 2 Description of the interview process
Table 2 Baseline demographics of the included 15 women
Numbers
of women
Age 65–79 years (mean 71.9)
living with
spouse
8
children 0–4 (2 women had no children)
retired 13
employed 2
comorbidity cancer 6
hysterectomy 2
collagen disease 3
fracture 1
cardiac disease 2
hyper cholesterol 2
chronic pulmonary lung disease 4
metabolism 1
Scheuermann’s disease 1
more than one comorbidity 7
BMI≤ 19 3
menopause
<45y
4
hereditary
disposition
10
daily pain 8
smoking/
alcohol (use)
smoking: any/alcohol (use): above the
recommended 14 units per week
6/1
referral to DXA
scan due to
general practitioner (GP)
own request to GP
medical specialist
7
4
4
Exercise follows the radio’s morning
gymnastics program
5
Line Dance 1
rowing 1
daily walking 9
the municipality’s gymnastics for the
elderly, led by physiotherapist
4
always taking the stairs 3
more than one exercise form 8
Table 3 An overview of key themes and sub themes
Key themes Sub themes
To become influenced by the
medical treatment
- taking the medication
- discontinuing the
medication
Daily life with osteoporosis - interpretation of symptoms
- interpretation of scanning
result
- lifestyle reflections
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taken. The action was influenced by concerns about side
effects and other negative thoughts, but with a clear
willingness to take medication and make it work by
planning how to remember to take it once a week.
“The first time I took it I thought it was such an
execution pill, probably a really strong one. I decided
to take it Friday morning before the weekend. (…) I
bought a green box and I dispensed for a week. On
Fridays, I have attached a big red star. (…) The star
tells me I cannot eat or drink anything before or lie
down and all that” (5)
Osteoporosis is perceived as a condition that requires
preventative action, as well as a disease to be taken
seriously. Strategies for remembering to take the medi-
cation were described as being necessary.
Despite a continued and comprehensive focus on what
were perceived as side effects and the risk of developing
side effects six month after diagnosis, it appeared that de-
veloping medication-taking strategies became more natural
after the conversion to life with osteoporosis took place.
Six months after her diagnosis, an informant told us:
“I take it Saturday morning when I get up. (…) I go for
a walk, take a shower or walk back and forth. Then
that hour has elapsed” (12)
In some instances, the ease of preventative treatment
emerged to be related to the treatment option of intraven-
ous osteoporosis medication. One year after diagnosis,
another informant claimed:
“I get infusions. It's only once a year and it is in May.
I've only got it twice so far. I feel no side effects or
anything” (13)
Despite the general ease of the treatment, thoughts
about side effects were prevalent in this case. This was
mainly in the third round of interviews, one year after the
diagnosis, where some degree of having obtained calm and
coming to terms with the medical treatment emerged.
This was in regard to both the perspective of deciding to
take the medication as well as in light of convincing
themselves that it is the best thing to do. In contrast,
few women described the ease of treatment, which
consisted of an immediate decision to follow the phy-
sician’s prescription without much reflection about
this issue later on.
Discontinuing the medication
Discontinuing the medication appeared in the text as a
process based on experiences during the first year after
diagnosis. Three women either stopped or did not initi-
ate recommended osteoporosis medication; all filled
their prescription at least once.
In the first interview round shortly after the diagnosis
the main focus was on concerns related to side effects:
“I did find an article.(…) There I read about making
the dentist aware of it (…) It has something to do with
the healing process of the jaw (…) If they [the tablets]
are uncomfortable in some ways’ I am not sure (pause).
I believe the medicine is a little harsh” (3)
These concerns were described in connection to new
knowledge obtained through seeking information about
the medication. Moreover, some signs of insecurity re-
lated to the decision could be traced in this stage of the
process. Six months later, concerns about the medication
have developed in terms of own experiences of discom-
fort or side effects leading to reflections on the decision
to discontinue the medication:
“I felt weird in my stomach (…) I did not sleep well the
first nights. (…) Maybe it's mental, but I really don't
like taking them. I got the feeling that they were
unpleasantly rough to my stomach. (…) Then I
stopped taking them. I was wondering if they are so
harsh, is it then worth taking them?” (15)
Not being worried about treatment side effects can be
a relief. On the other hand, some insecurity regarding
the decision to discontinue the medication is interpreted
in the text. The interpretation of a degree of insecurity
regarding the decision is strengthened by narratives of
continuing to seek information and advice from various
sources at this stage. One year after diagnosis at the
third round of interviews, a certain calm related to com-
ing to terms with the decision to discontinue the medi-
cation was found.
“I’ve got heart problems (…) it has overlapped with it
[osteoporosis]. It is more important that the heart
beats than I might have to sit in a wheelchair. I have
chosen not to take the medication [anti-osteoporotic]. I
am instead trying to do everything else to strengthen
my bones” (3)
In this particular case, the experience of the decision
was influenced by a larger life event of dealing with a
potential heart failure.
Another perspective of the decision process regarding
the medical treatment was also found in the text, as one
woman described persistent resistance towards taking
the medication in the first interview. Throughout the
second interview, she maintained a strong resistance and
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a firm decision not to take the medication, although
there was the twist of doing as she “was told”.
“I'm not bothered by anything. I do not take those
stupid pills. No I don't. I hate to take pills. The GP
who gave them to me said that I might get side effects.
I said ‘you know what? I do not want them it works
just fine’. (…) On the other hand I am very (pause) I
obey the doctor [she bought them anyway]” (11)
A pronounced reserved attitude towards taking medi-
cation was a general finding, although this example was
the most distinct.
Daily life with osteoporosis
The theme “daily life with osteoporosis” was supported
in the text by descriptions of a trajectory and evolution
of experiences related to three subthemes: “interpret-
ation of symptoms”; “interpretation of scanning result”
and “lifestyle reflections” (Table 3).
Interpretation of symptoms
The sub theme “interpretation of symptoms” contains
experiences relating to the interpretation of osteoporosis
through finding explanations and developing under-
standing of the evolution of increased or reduced symp-
toms of side effects, back pain and other physical
symptoms. The individual interpretation and under-
standing of osteoporosis as being the reason for what
had been causing back pain for many years began shortly
after the diagnosis:
“It's [osteoporosis] apparently something that comes
sneaking (…) I have not been able to understand why I
got sore back again and again. I HAVE had back pain
as if it explodes” (1)
The diagnosis is found to generate a cognitive process
which brings a new perspective when learning to live
with osteoporosis. In addition, trust that the physician
would be able to provide help in understanding and
interpreting the symptoms also appeared:
“My GP has promised to help me find out about the
pain I have. Whether it is associated with osteoporosis
or whether it is something else. (…) He has to tell
me what to do. (…) I have experienced that one can
learn to live with pain. I am not just sitting in a
chair” (10)
Learning to live with osteoporosis is found to be based
on an acceptance of the diagnosis generated though an
understanding of symptoms as being related to osteo-
porosis. This process began shortly after the diagnosis
but was generally clarified in the third round of inter-
views by descriptions of feelings verifying the diagnosis.
When the symptoms declined, it was interpreted as be-
ing due to the pharmaceutical treatment stressing that
the diagnosis was real. Approximately one year after the
diagnosis, an informant stated:
“I've been so ill, so I couldn't even pull the quilt up.
Finally, I got it, ‘forsteo’. I have taken it for a year now.
(…) The past one and a half months I sometimes wake
up in the morning without having backache” (9)
This kind of reflection on symptoms emerged to be a
common part of the cognitive process of accepting a
future life with osteoporosis.
Interpretation of the DXA result
The sub theme interpretation of the scan result contains
descriptions of the interpreted value along with the
understanding of the scan result. In several cases, it
appeared to be difficult for the women to understand
the result of their scan. In the first interview, one
woman said:
“Approximately three years ago I decided to get it
[osteoporosis] examined, I was over the line, but far
down [on the scale]. (…) In this fall I got it reassessed.
(…) the numbers [from the DXA scan result] were
almost the same but finally it was addressed (…) they
said I have osteoporosis” (14)
Despite the participants’ difficulties in interpreting
results from DXA scans, the scan results were perceived
as being of significance for the development of under-
standing and acceptance of the diagnosis. It appeared in
the text that these results were commonly used in the
process of learning to live with osteoporosis. Six months
after the diagnosis one woman noted:
“My sister was here recently. We compared her
pictures with mine, and the values. (…) I don’t know
when I am having the next scan. (…) I don’t know how
fast you can see an effect [of the treatment on a DXA
scan result]” (4)
The scanning result served as a form of verification of
the diagnosis, and was expected to confirm the effects of
the treatment. About one year after the diagnosis, an
informant claimed:
“In December I’ll have to sign up for a new scan. Then
we'll see if it shows any change. Some improvement
hopefully (pause) or maybe there has been very little
change” (2)
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In addition, expectations regarding the next scanning
result were found to be of value, since this was talked
about as being the “proof” of whether the treatment was
effective. As clarified by the quote, throughout the text
future expectations were related to the hope of visual
signs of improvement.
Lifestyle reflections
The sub theme “lifestyle reflections” was found to be a
process mediating the acceptance and adaption to learn-
ing to live with osteoporosis. This was described in the
text as experiences of daily life shortly after the diagnosis
(at the first rounds of interviews), focusing on informa-
tion or thoughts related to lifestyle advice when living
with osteoporosis. This was further elaborated through
the second round of interviews which primarily focused
on changes related to diet and physical activity. In the
third round of interviews, we found continued reflec-
tions relating to diet and physical activity as well as prior
lifestyle. The process is illuminated by descriptions of
the potential insecurity of a future life with osteoporotic
consequences and how to prevent these consequences.
Shortly after the diagnosis:
“I am confused; I do not know what might harm. (…) I
want to do preventive things as much as possible.
(…)Does it takes ten years to develop a fracture or
how fast? How unfortunate can I be? Will something
suddenly break? Many people are having pain. That is
turning around in my head after I have been told that I
have osteoporosis” (8)
The fear of possible future consequences of osteoporosis
emerged throughout the text and was found to both medi-
ate and challenge the process of acceptance. Reflections
and concerns about “doing the right thing” were often
expressed in conjunction with experiences of differing and
confusing information and perceptions of lifestyle advice
(in this example intake of supplemented intake of cal-
cium). At the second interview, an informant claimed:
“I have always been exercising, I have been eating
healthily and I do not smoke and I do not drink. I
think I have done what I could to have a healthy life.
(…) I am always thinking whether I get enough calcium.
At the pharmacy they say I have to take three tablets a
day, otherwise I have been told that I have to take two a
day, what am I supposed to do? (…) I am sort of pushing
it in front of me all the time. Am I doing it right? Am I
generating a hunched back or get a fracture? What will
happen?” (15)
Coming to terms with new life circumstances and trying
to do ‘the right thing’ was made more difficult by what
was perceived as confusing and differing information.
Moreover, understanding and acceptance of the diagnosis
was obtained by interpretation and explanations through
narratives of a former lifestyle as exemplified in the third
round of interviews:
“I've known for many years that I probably had it
[osteoporosis]. As a child I did not like milk. I had
some allergies. (…) I still do not like milk therefore it is
important to incorporate calcium in my food other
than calcium tablets. I eat ten to twelve almonds every
morning. (…) I eat sardines in oil and tuna in oil they
are a little fat and have vitamin D” (7)
Part of the process of coming to terms to living with
osteoporosis involved seeking an explanation to why the
patients had developed osteoporosis. Most cases in-
cluded reflections on “why”.
Exceptions from the cognitive process of learning to
live with osteoporosis were found in a small number of
women who appeared to be occupied with other issues,
such as having a severe comorbidity, taking care of an ill
spouse or just perceiving it as a “natural thing”:
“We've a good life. He [the husband] is not able to
talk. He has aphasia and a half-side paralysis. His mood
is good. We have learned to live with that side of our
lives, and that is more important than osteoporosis. (…)
I do not know what to do about it, so I don't do anything.
I missed instructions. I hardly know what osteoporosis
is. That's probably why it does not make as much
impression on me” (6)
The process of learning to live with osteoporosis was
generally found to be highly influenced by the percep-
tion of pharmaceutical treatment. The understanding
and interpretation of information and medical advice,
together with the interpretation of symptoms and scan
results were, together with the interviewees’ prior life-
style, exposed to a deeper reflection. The perceptions of
a future DXA scan emerged as an important life event,
with expectations and hope for an improved result.
Discussion
The study adds knowledge to how women, who had not
experienced an osteoporosis fracture at the time of diag-
nosis, learn to live with osteoporosis after being pre-
scribed pharmaceutical treatment. The experiences
described a multifaceted process that is highly influenced
by the medical treatment and daily life. The inter-
viewees’ daily lives were found to be adapted according
to understanding and interpreting of a bigger picture of
lifestyle, including bodily “signals” such as past and
current symptoms, pain, side effects (or what were
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perceived as being side effects) as well as the scan re-
sults. Moreover, accepting and understanding of the
diagnosis was found to be dependent on the adaptation
of daily life, and vice versa.
Medical aspects such as having to take medication and
side effects have an important role in life with osteopor-
osis and perhaps especially before a known osteoporotic
fracture occurs, since the medication is tangible and has
to be managed in one way or another. It may be as-
sumed that the reason why most women are continu-
ously focused on side effects during the first year after
diagnosis is due to their understanding of benefits of
having been diagnosed and understanding of the import-
ance of the pharmaceutical fracture preventative therapy
in decreasing the risk of osteoporotic fractures. Our
findings on this central issue contribute to the findings
of other studies dealing with treatment-requiring osteo-
porosis, the initiation of pharmaceutical treatment as
well as persisting and complying with anti-osteoporotic
therapy [8, 21, 29, 44, 52–54]. Yu et al. specifically inves-
tigated reasons for not initiating osteoporosis therapy
[54]. They found that 37.6% of 117 survey responders
did not initiate recommended osteoporosis medication
due to concerns over side effects in 77.3% of the cases.
These findings may be seen as consistent with findings
in the current study.
The current findings of accepting and understanding
the diagnosis are in accordance with studies by Kralik et
al. [55, 56] who explored women’s narratives of “being”
diagnosed with a long-term illness [55] and the process
of “moving on” when living with a chronic illness or
condition [56]. The studies reported that many women
experienced receiving the medical diagnosis of their
long-term illness as a memorable event in their lives; the
experience of getting a diagnostic label was comprehen-
sive and should not be underestimated [55]. Addition-
ally, it was reported that “moving on” with a chronic
illness or a condition is a complex process of learning,
finding meaning and the redefining of self - a unique
journey for each person depending upon their particular
situation and context [56]. This was in line with what
the women in our study described when reflecting on
their lifestyle and trying to understand why they have
developed osteoporosis, and how to live their daily lives
with this chronic disease. This process may not be spe-
cific to osteoporosis, and healthcare professionals treat-
ing osteoporosis patients may benefit and learn from
studies on other chronic diseases
Similarities may be drawn to the grounded theory
study of “healthy risk awareness” [27], which develops
through an emotional cognitive process of acceptance.
Being motivated to act in a preventative way was found
to impact upon acceptance, which underwent a develop-
ment through the fear of having fragile bones [27].
Descriptions of fear in the current study were primarily
elaborated through concerns related to the medical
treatment, side effects and making the right choice, but
also concerns regarding possible fractures [44]. These
worries were addressed by developing strategies and
making adjustments in everyday life. This may be under-
stood as being generated by fear being used to develop
“healthy risk awareness” as found in the study by Hjal-
marson et al. Developing strategies by taking control has
been found to be a way of addressing a negative out-
come such as having fractures [8]. Moreover, it was
found that strategies have been developed when patients
accepted their need for treatment [28]. In the current
study, acceptance appeared to be mediated by the per-
ception of the medical treatment. The women were con-
fused by differing information and medical advice from
across various sources. They sought to understand the
information and interpret their symptoms, side effects
and the results of their scan within a bigger picture of
daily life with osteoporosis. Significant parts of this un-
derstanding and interpretation of the accepting process
were related to the decisions regarding taking or discon-
tinuing the medication. The individual perception ap-
pears to be an important factor, which should be
highlighted when dealing with osteoporotic fracture pre-
vention. One of the most pronounced challenges is to
uncover factors which may increase adherence to anti-
osteoporotic treatment. In a large national register-based
study, it was found that 38.7% of the patients stopped
treatment within the first year [23]. Although this is of a
smaller scale when compared to international findings
[21, 22, 24, 25], it is still a problem from a fracture pre-
vention perspective [16]. The decision-making process
has been reported in other studies to be an emotional
and cognitive learning process [27]; a sense-making
process [8]; and a process of trial and error to find useful
strategies [28]. One common limitation of these and
other qualitative studies that investigate the decision-
making process regarding medication use of individuals
with osteoporosis appears to be the lack of studies with
longitudinal design following patients’ experiences over
time (no qualitative studies on this matter were found).
The multifaceted factors which were found to be related
to decision-making in the current study may be the ex-
planation of why it was found to be a matter of an im-
mediate decision for some, while for others, it was a
longer process that developed over time. This finding
may be supported by the study of challenges regarding
transition to a life with chronic illness [56].
Implications for research and practice
Interventions targeting osteoporotic fracture prevention
that encourage collaboration between patients and health-
care professionals may incorporate approaches of shared
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decision-making or other equivalent approaches for per-
sistence of use enhancement and patient education. Shared
decision-making has been found to be the most effective
therapeutic option to increase compliance and persistence
to medical treatment, together with fostering greater pa-
tient satisfaction and improving the healthcare processes
and outcomes for patients [57]. It may, however, be diffi-
cult to implement this model, as healthcare professionals
may find it hard to take a health-(and an individual) ori-
ented stance and focus on the particular patient’s reaction
to the illness in daily life, as it is different from the disease-
oriented perspective [58]. Despite potential difficulties, the
current study highlights the importance of making room
for patients’ individual narratives to strengthen their em-
powerment. The stories told by patients may naturally find
their place as a part of the nursing consultation in the out-
patient clinic. A participant-oriented direction requires
innovation among healthcare professionals.
Further research is needed. We therefore suggest that
further intervention studies comparing current practice to
more individualized plans for decision-making adapting to
individuals’ need for access to professional advice (such as
nursing consultations, telephone hotline or telemedicine
[57–59]) may be beneficial when targeting osteoporotic
fracture prevention and learning to live with osteoporosis.
Other perspectives, based on the current study results,
may provide the opportunity of developing targeted
register-based studies. The current study suggests that
there is a need for more targeted surveys of patients and
healthcare professionals examining their attitude and
assessments of information of the treatment, the condi-
tion, socio-demographic and health-related factors etc.
Strengths and limitations of the study
The reporting of this qualitative study has sought to meet
the recommendations of The Consolidated criteria for
reporting qualitative research (COREQ): a 32-item check-
list for interviews and focus groups (Additional file 2)
[60]. This instrument is recommended by BioMed Cen-
tral. The study comprised of 42 interviews involving 15
participants. This number may be seen as a strength of
the study. Additionally, the longitudinal design is consid-
ered to provide a thorough exploration of the research
question [43]. Since the survey only included women
over the age of 65 who voluntarily participated in the
study, it is possible to assume, for instance, that
younger woman or those who chose not to participate
would have brought a different perspective to the
results.
Five interviews were conducted by telephone - this
was chosen at the convenience of the participants to
ensure participation. Telephone interviews can be an
effective method of data collection when the interviewer
is aware of the challenges involved [61]. When conducting
telephone interviews the ability to observe non-verbal
communication is missing; instead, however, the tone of
the voice can be taken into consideration to conjure a
picture of the individual [62]. Based on the previous inter-
actions, we did not get the impression that the interviews
by telephone affected the data.
The interviews in this study allowed for open, nuanced
descriptions of various aspects of women’s lives after the
diagnosis when medical treatment was prescribed. The
appearance of the phenomenon “life with osteoporosis”
was enabled.
No qualitative study is without the “touch” or influence
of the investigation itself or the researcher as an “interact-
ing” individual. When conducting qualitative research, it is
crucial to reflect upon possibilities of how the researcher
affects the process or whether such an effect can be pre-
vented, during data collection, analysis and interpretation
[63]. During interviews, the first author sought to be
aware of own preconceptions, not posing leading ques-
tions but instead giving the women the opportunity to tell
their story and time to pause during its narration, after
which the women were encouraged to elaborate upon
something they had mentioned with the purpose of clari-
fying the meaning attached to the individual experience.
Analysis and interpretation were discussed with fellow
researchers (CAH: female, AB: male, HK: female and
BDP: female) during all three levels of the interpretation
to enhance trustworthiness. Involvement of multiple re-
searchers is recommended when conducting qualitative
research, as this might strengthen the design of a study.
During the analysis process and interpretation multiple
researchers may supplement and contest each other’s
statements which may enrich and qualify the analysis
[49, 63].
Conclusion
Women’s experiences of living with osteoporosis the first
year after diagnosis were characterized by a complex
process of learning to live with their new life circum-
stances. This process was found to be highly influenced
by finding strategies that encompass taking the medica-
tion, side effects or concerns about side effects, the ac-
ceptance and interpretation of scan results, symptoms
and the diagnosis, as well as decision-making. There is a
need for communication tailored to individual needs,
since the uncertainty of living with the new life circum-
stances may be overwhelming and may lead to inappro-
priate decisions which could affect pharmaceutical
treatment. Improved individualized support for women
in the process of learning to live with osteoporosis may
be improved through using a health-oriented stance.
More research is needed from the perspective of both
health promotion and prevention.
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